SyedNaqviMDMBA
Internal Medicine • Columbia, MOHospital Medicine/Hospitalist
Professor of Clinical Medicine
Dr. Naqvi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
One Hospital Dr
Columbia, MO 65212Phone+1 573-884-9066Fax+1 573-884-3037
Summary
- Dr. Syed Hasan Naqvi is an internist in Columbia, MO and is affiliated with University of Missouri Health Care. He received his medical degree from Allama Iqbal Medical College and has been in practice 17 years. He specializes in hospital medicine/hospitalist.
Education & Training
University of Missouri MBA, Executive , 2020 - 2022
NYU Grossman School of Medicine/Brooklyn CampusResidency, Internal Medicine, 2004 - 2007
Allama Iqbal Medical CollegeClass of 2000
Certifications & Licensure
MO State Medical License 2013 - 2025
GA State Medical License 2009 - 2014
WI State Medical License 2007 - 2011- American Board of Internal Medicine Internal Medicine
Clinical Trials
- Randomized, Open-Label, Multicenter, Controlled, Pivotal Study to Assess Safety and Efficacy of ELAD in Subjects w/ AILD Start of enrollment: 2016 Jan 01
- A Study of Auxora in Patients With Acute Pancreatitis and Accompanying SIRS Start of enrollment: 2021 Mar 24
- A Study of OCE-205 in Participants With Cirrhosis With Ascites Who Developed Hepatorenal Syndrome-Acute Kidney Injury Start of enrollment: 2022 Apr 28
Publications & Presentations
PubMed
- 160 citationsAcute Ischemic Stroke and COVID-19: An Analysis of 27 676 Patients.Adnan I Qureshi, William I. Baskett, Wei Huang, Daniel Shyu, Danny Myers
Stroke. 2021-02-04 - 171 citationsEvolutionary analysis of the Delta and Delta Plus variants of the SARS-CoV-2 viruses.Saathvik R. Kannan, Austin N. Spratt, Alisha R. Cohen, S. Hasan Naqvi, Hitendra S. Chand
Journal of Autoimmunity. 2021-08-11 - 3 citationsIslatravir: evaluation of clinical development for HIV and HBV.Samuel W Gillespie, Athreya S Reddy, Dana M Burris, S Hasan Naqvi, Siddappa N Byrareddy
Expert Opinion on Investigational Drugs. 2024-02-01
Authored Content
- Islatravir: evaluation of clinical development for HIV and HBV, Expert Opinion on Investigational Drugs,January 2024
Professional Memberships
- SFHM
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
